PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lian, X.* ; Xia, Z. ; Li, X.* ; Karpov, P. ; Jin, H.* ; Tetko, I.V. ; Xia, J.* ; Wu, S.*

Anti-MRSA drug discovery by ligand-based virtual screening and biological evaluation.

Bioorg. Chem. 114:105042 (2021)
Postprint DOI PMC
Open Access Green
S. aureus resistant to methicillin (MRSA) is one of the most-concerned multidrug resistant bacteria, due to its role in life-threatening infections. There is an urgent need to develop new antibiotics against MRSA. In this study, we firstly compiled a data set of 2,3-diaminoquinoxalines by chemical synthesis and antibacterial screening against S. aureus, and then performed cheminformatics modeling and virtual screening. The compound with the Specs ID of AG-205/33156020 was discovered as a new antibacterial agent, and was further identified as a Gyrase B (GyrB) inhibitor. In light of the common features, we hypothesized that the 6c as the representative of 2,3-diaminoquinoxalines also inhibited GyrB and eventually proved it. Via molecular docking and molecular dynamics simulations, we identified binding modes of AG-205/33156020 and 6c to the ATPase domain of GyrB. Importantly, these GyrB inhibitors inhibited the MRSA strains and showed selectivity to HepG2 and HUVEC. Taken together, this research work provides an effective ligand-based computational workflow for scaffold hopping in anti-MRSA drug discovery, and discovers two new GyrB inhibitors that are worthy of further development.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
5.275
1.408
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Antibacterial Agent ; Antibiotic Resistance ; Dna Gyrase Inhibitors ; Mrsa ; Virtual Screening; Dna Gyrase; Antibiotics; Inhibitors
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0045-2068
e-ISSN 1090-2120
Zeitschrift Bioorganic chemistry
Quellenangaben Band: 114, Heft: , Seiten: , Artikelnummer: 105042 Supplement: ,
Verlag Elsevier
Verlagsort San Diego, Calif.
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Structural Biology (STB)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503000-001
Förderungen China Scholarship Council (CSC)
PUMC Graduate Students Innovation Fund
CAMS Innovation Fund for Medical Sciences
DOI 10.1016/j.bioorg.2021.105042
WOS ID WOS:000689722000001
Scopus ID 85107693068
PubMed ID 34120024
Erfassungsdatum 2021-07-12
[➜Korrektur melden]